Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for TRDA

Stock Name	Entrada Therapeutics Inc
Ticker	TRDA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US29384C1080

Show aggregate TRDA holdings

News associated with TRDA

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Receives $25.67 Average Price Target from Brokerages: Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) has received an average recommendation of “Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The […] - 2025-09-12 02:01:10
Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 6,935 Shares of Stock: Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 6,935 shares of the firm’s stock in a transaction dated Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total value of $52,012.50. Following the sale, the insider directly owned 1,093,313 shares of the […] - 2025-07-14 06:12:51
Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 20,065 Shares of Stock: Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 20,065 shares of the stock in a transaction dated Wednesday, July 9th. The shares were sold at an average price of $7.50, for a total value of $150,487.50. Following the completion of the transaction, the insider owned 3,163,066 shares of […] - 2025-07-14 05:38:49
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Sells $202,500.00 in Stock: Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) Director Kush Parmar sold 27,000 shares of the stock in a transaction that occurred on Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total transaction of $202,500.00. Following the sale, the director owned 1,093,313 shares in the company, valued at […] - 2025-07-14 05:38:48
Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell?: Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 3.6% during mid-day trading on Monday . The company traded as low as $6.87 and last traded at $6.97. 149,403 shares traded hands during trading, an increase of 11% from the average session volume of 134,750 shares. The stock had previously closed at $7.23. […] - 2025-07-08 04:35:07
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 152.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 35,750 shares of the company’s stock after acquiring an additional 21,594 shares during […] - 2025-06-12 05:12:44
First Trust Advisors LP Cuts Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA): First Trust Advisors LP decreased its position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 9.6% during the fourth quarter, HoldingsChannel reports. The firm owned 73,749 shares of the company’s stock after selling 7,800 shares during the period. First Trust Advisors LP’s holdings in Entrada Therapeutics were worth $1,275,000 at the end […] - 2025-05-08 05:54:57
Barclays PLC Has $887,000 Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA): Barclays PLC grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 13.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,365 shares of the company’s stock after purchasing an additional 6,255 shares during the period. Barclays PLC’s holdings in […] - 2025-05-06 04:40:49
Geode Capital Management LLC Cuts Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA): Geode Capital Management LLC trimmed its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 573,891 shares of the company’s stock after selling 2,560 shares during […] - 2025-04-23 05:06:55
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Holdings Increased by Federated Hermes Inc.: Federated Hermes Inc. boosted its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 3,104.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 99,814 shares of the company’s stock after purchasing an additional 96,699 shares during the period. Federated Hermes Inc. owned about […] - 2025-04-15 04:54:50
Arrowstreet Capital Limited Partnership Has $3.85 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA): Arrowstreet Capital Limited Partnership increased its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 123.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 222,520 shares of the company’s stock after acquiring an additional 122,823 shares during the quarter. Arrowstreet Capital […] - 2025-04-09 05:30:53
AlphaQuest LLC Invests $70,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA): AlphaQuest LLC purchased a new position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 4,046 shares of the company’s stock, valued at approximately $70,000. A number of other large investors have also recently made changes to their positions in TRDA. Janus Henderson Group PLC […] - 2025-03-20 06:12:50
Entrada Therapeutics (NASDAQ:TRDA) Receives Buy Rating from HC Wainwright: Entrada Therapeutics (NASDAQ:TRDA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $20.00 price objective on the stock. HC Wainwright’s price target suggests a potential upside of 66.39% from the company’s previous close. TRDA has been […] - 2025-02-27 06:44:55
China Universal Asset Management Co. Ltd. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA): China Universal Asset Management Co. Ltd. bought a new position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,931 shares of the company’s stock, valued at approximately $137,000. A number of other […] - 2025-02-04 07:03:05

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TRDA holdings

Date	Number of TRDA Shares Held	Base Market Value of TRDA Shares	Local Market Value of TRDA Shares	Change in TRDA Shares Held	Change in TRDA Base Value	Current Price per TRDA Share Held	Previous Price per TRDA Share Held
2026-01-15 (Thursday)	25,824	USD 279,416	USD 279,416	120	USD 7,468	USD 10.82	USD 10.58
2026-01-14 (Wednesday)	25,704	USD 271,948	USD 271,948	120	USD 4,339	USD 10.58	USD 10.46
2026-01-13 (Tuesday)	25,584	USD 267,609	USD 267,609	0	USD 13,048	USD 10.46	USD 9.95001
2026-01-12 (Monday)	25,584	USD 254,561	USD 254,561	120	USD -588	USD 9.95001	USD 10.02
2026-01-09 (Friday)	25,464	USD 255,149	USD 255,149	180	USD -10,839	USD 10.02	USD 10.52
2026-01-08 (Thursday)	25,284	USD 265,988	USD 265,988	0	USD -5,815	USD 10.52	USD 10.75
2026-01-07 (Wednesday)	25,284	USD 271,803	USD 271,803	120	USD 18,150	USD 10.75	USD 10.08
2026-01-06 (Tuesday)	25,164	USD 253,653	USD 253,653	0	USD -10,569	USD 10.08	USD 10.5
2026-01-05 (Monday)	25,164	USD 264,222	USD 264,222	0	USD 11,324	USD 10.5	USD 10.05
2026-01-02 (Friday)	25,164	USD 252,898	USD 252,898	60	USD -5,171	USD 10.05	USD 10.28
2025-12-31 (Wednesday)	25,104	USD 258,069	USD 258,069	0	USD 4,770	USD 10.28	USD 10.09

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRDA by Blackrock for IE00BDZVHG35

Show aggregate share trades of TRDA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 120 10.820* 9.12
2026-01-14 BUY 120 10.580* 9.11
2026-01-12 BUY 120 9.950* 9.10
2026-01-09 BUY 180 10.020* 9.09
2026-01-07 BUY 120 10.750* 9.08
2026-01-02 BUY 60 10.360 9.840 9.892 USD 594 9.06
2025-12-30 BUY 60 10.280 9.961 9.993 USD 600 9.05
2025-12-23 SELL -720 10.865 10.460 10.501 USD -7,560 9.01 Loss of -1,070 on sale
2025-12-19 SELL -4,018 11.250 10.680 10.737 USD -43,141 8.99 Loss of -7,000 on sale
2025-12-17 SELL -350 11.510 11.110 11.150 USD -3,902 8.97 Loss of -763 on sale
2025-12-16 SELL -70 11.440 10.820 10.882 USD -762 8.96 Loss of -135 on sale
2025-12-15 BUY 140 11.355 10.850 10.901 USD 1,526 8.95
2025-12-11 BUY 142 11.045 10.520 10.573 USD 1,501 8.92
2025-12-04 BUY 1,380 10.384 9.520 9.606 USD 13,257 8.88
2025-12-02 BUY 1,050 9.990 9.490 9.540 USD 10,017 8.86
2025-11-28 BUY 70 10.315 9.910 9.950 USD 697 8.85
2025-11-26 BUY 210 10.325 9.960 9.997 USD 2,099 8.83
2025-11-25 BUY 350 10.750 10.110 10.174 USD 3,561 8.82
2025-11-24 BUY 70 10.450 9.635 9.717 USD 680 8.82
2025-11-20 SELL -276 9.290 8.780 8.831 USD -2,437 8.81 Loss of -7 on sale
2025-11-19 BUY 69 8.915 8.435 8.483 USD 585 8.81
2025-11-18 BUY 414 9.115 8.300 8.382 USD 3,470 8.81
2025-11-17 BUY 138 9.040 8.170 8.257 USD 1,139 8.81
2025-11-14 BUY 69 9.150 8.510 8.574 USD 592 8.81
2025-11-12 BUY 69 8.075 7.370 7.440 USD 513 8.82
2025-11-10 BUY 69 7.320 6.910 6.951 USD 480 8.83
2025-11-06 BUY 69 7.100 6.090 6.191 USD 427 8.86
2025-11-04 BUY 70 6.810 6.380 6.423 USD 450 8.89
2025-10-30 BUY 350 7.020 6.600 6.642 USD 2,325 8.93
2025-10-29 BUY 140 6.890 7.410 7.358 USD 1,030 8.94
2025-10-22 SELL -276 6.310 6.490 6.472 USD -1,786 9.02 Profit of 703 on sale
2025-10-20 BUY 138 6.250 6.330 6.322 USD 872 9.06
2025-10-17 BUY 344 5.870 6.245 6.207 USD 2,135 9.08
2025-10-15 BUY 544 6.190 6.260 6.253 USD 3,402 9.10
2025-10-03 BUY 490 6.000 6.140 6.126 USD 3,002 9.15
2025-10-02 BUY 70 5.920 6.058 6.044 USD 423 9.18
2025-09-30 BUY 140 5.800 5.840 5.836 USD 817 9.23
2025-09-26 BUY 140 5.800 5.918 5.906 USD 827 9.28
2025-09-25 BUY 140 5.580 5.640 5.634 USD 789 9.31
2025-09-18 BUY 70 5.550 5.755 5.735 USD 401 9.34
2025-09-17 BUY 210 5.090 5.505 5.464 USD 1,147 9.38
2025-07-17 SELL -138 6.380 6.625 6.601 USD -911 9.49 Profit of 399 on sale
2025-07-11 SELL -560 6.550 6.840 6.811 USD -3,814 9.59 Profit of 1,557 on sale
2025-07-02 BUY 3,850 7.270 7.410 7.396 USD 28,475 9.68
2025-06-25 BUY 138 7.060 7.190 7.177 USD 990 9.78
2025-06-11 BUY 140 7.900 8.475 8.418 USD 1,178 10.03
2025-06-10 BUY 140 8.260 8.490 8.467 USD 1,185 10.05
2025-06-04 SELL -70 7.930 8.500 8.443 USD -591 10.13 Profit of 118 on sale
2025-04-23 BUY 69 8.710 9.230 9.178 USD 633 10.98
2025-04-10 SELL -552 7.850 8.240 8.201 USD -4,527 11.48 Profit of 1,808 on sale
2025-04-08 SELL -69 7.550 8.720 8.603 USD -594 11.61 Profit of 208 on sale
2025-04-07 SELL -69 8.190 8.600 8.559 USD -591 11.68 Profit of 215 on sale
2025-04-04 SELL -350 7.940 7.990 7.985 USD -2,795 11.76 Profit of 1,320 on sale
2025-04-01 BUY 2,767 8.760 9.440 9.372 USD 25,932 11.88
2025-03-31 SELL -180 9.040 9.430 9.391 USD -1,690 11.94 Profit of 459 on sale
2025-03-14 SELL -960 10.810 11.140 11.107 USD -10,663 12.42 Profit of 1,259 on sale
2025-03-07 SELL -120 10.770 11.040 11.013 USD -1,322 12.68 Profit of 200 on sale
2025-03-04 SELL -60 10.990 11.490 11.440 USD -686 12.90 Profit of 87 on sale
2025-02-25 BUY 120 12.120 13.170 13.065 USD 1,568 13.12
2025-02-19 SELL -60 13.000 13.219 13.197 USD -792 13.14 Loss of -3 on sale
2025-02-13 BUY 180 12.630 12.850 12.828 USD 2,309 13.14
2025-02-12 BUY 60 12.690 13.000 12.969 USD 778 13.18
2025-02-11 BUY 240 12.240 12.910 12.843 USD 3,082 13.25
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	120			10.820*		9.12
2026-01-14	BUY	120			10.580*		9.11
2026-01-12	BUY	120			9.950*		9.10
2026-01-09	BUY	180			10.020*		9.09
2026-01-07	BUY	120			10.750*		9.08
2026-01-02	BUY	60	10.360	9.840	9.892	USD 594	9.06
2025-12-30	BUY	60	10.280	9.961	9.993	USD 600	9.05
2025-12-23	SELL	-720	10.865	10.460	10.501	USD -7,560	9.01 Loss of -1,070 on sale
2025-12-19	SELL	-4,018	11.250	10.680	10.737	USD -43,141	8.99 Loss of -7,000 on sale
2025-12-17	SELL	-350	11.510	11.110	11.150	USD -3,902	8.97 Loss of -763 on sale
2025-12-16	SELL	-70	11.440	10.820	10.882	USD -762	8.96 Loss of -135 on sale
2025-12-15	BUY	140	11.355	10.850	10.901	USD 1,526	8.95
2025-12-11	BUY	142	11.045	10.520	10.573	USD 1,501	8.92
2025-12-04	BUY	1,380	10.384	9.520	9.606	USD 13,257	8.88
2025-12-02	BUY	1,050	9.990	9.490	9.540	USD 10,017	8.86
2025-11-28	BUY	70	10.315	9.910	9.950	USD 697	8.85
2025-11-26	BUY	210	10.325	9.960	9.997	USD 2,099	8.83
2025-11-25	BUY	350	10.750	10.110	10.174	USD 3,561	8.82
2025-11-24	BUY	70	10.450	9.635	9.717	USD 680	8.82
2025-11-20	SELL	-276	9.290	8.780	8.831	USD -2,437	8.81 Loss of -7 on sale
2025-11-19	BUY	69	8.915	8.435	8.483	USD 585	8.81
2025-11-18	BUY	414	9.115	8.300	8.382	USD 3,470	8.81
2025-11-17	BUY	138	9.040	8.170	8.257	USD 1,139	8.81
2025-11-14	BUY	69	9.150	8.510	8.574	USD 592	8.81
2025-11-12	BUY	69	8.075	7.370	7.440	USD 513	8.82
2025-11-10	BUY	69	7.320	6.910	6.951	USD 480	8.83
2025-11-06	BUY	69	7.100	6.090	6.191	USD 427	8.86
2025-11-04	BUY	70	6.810	6.380	6.423	USD 450	8.89
2025-10-30	BUY	350	7.020	6.600	6.642	USD 2,325	8.93
2025-10-29	BUY	140	6.890	7.410	7.358	USD 1,030	8.94
2025-10-22	SELL	-276	6.310	6.490	6.472	USD -1,786	9.02 Profit of 703 on sale
2025-10-20	BUY	138	6.250	6.330	6.322	USD 872	9.06
2025-10-17	BUY	344	5.870	6.245	6.207	USD 2,135	9.08
2025-10-15	BUY	544	6.190	6.260	6.253	USD 3,402	9.10
2025-10-03	BUY	490	6.000	6.140	6.126	USD 3,002	9.15
2025-10-02	BUY	70	5.920	6.058	6.044	USD 423	9.18
2025-09-30	BUY	140	5.800	5.840	5.836	USD 817	9.23
2025-09-26	BUY	140	5.800	5.918	5.906	USD 827	9.28
2025-09-25	BUY	140	5.580	5.640	5.634	USD 789	9.31
2025-09-18	BUY	70	5.550	5.755	5.735	USD 401	9.34
2025-09-17	BUY	210	5.090	5.505	5.464	USD 1,147	9.38
2025-07-17	SELL	-138	6.380	6.625	6.601	USD -911	9.49 Profit of 399 on sale
2025-07-11	SELL	-560	6.550	6.840	6.811	USD -3,814	9.59 Profit of 1,557 on sale
2025-07-02	BUY	3,850	7.270	7.410	7.396	USD 28,475	9.68
2025-06-25	BUY	138	7.060	7.190	7.177	USD 990	9.78
2025-06-11	BUY	140	7.900	8.475	8.418	USD 1,178	10.03
2025-06-10	BUY	140	8.260	8.490	8.467	USD 1,185	10.05
2025-06-04	SELL	-70	7.930	8.500	8.443	USD -591	10.13 Profit of 118 on sale
2025-04-23	BUY	69	8.710	9.230	9.178	USD 633	10.98
2025-04-10	SELL	-552	7.850	8.240	8.201	USD -4,527	11.48 Profit of 1,808 on sale
2025-04-08	SELL	-69	7.550	8.720	8.603	USD -594	11.61 Profit of 208 on sale
2025-04-07	SELL	-69	8.190	8.600	8.559	USD -591	11.68 Profit of 215 on sale
2025-04-04	SELL	-350	7.940	7.990	7.985	USD -2,795	11.76 Profit of 1,320 on sale
2025-04-01	BUY	2,767	8.760	9.440	9.372	USD 25,932	11.88
2025-03-31	SELL	-180	9.040	9.430	9.391	USD -1,690	11.94 Profit of 459 on sale
2025-03-14	SELL	-960	10.810	11.140	11.107	USD -10,663	12.42 Profit of 1,259 on sale
2025-03-07	SELL	-120	10.770	11.040	11.013	USD -1,322	12.68 Profit of 200 on sale
2025-03-04	SELL	-60	10.990	11.490	11.440	USD -686	12.90 Profit of 87 on sale
2025-02-25	BUY	120	12.120	13.170	13.065	USD 1,568	13.12
2025-02-19	SELL	-60	13.000	13.219	13.197	USD -792	13.14 Loss of -3 on sale
2025-02-13	BUY	180	12.630	12.850	12.828	USD 2,309	13.14
2025-02-12	BUY	60	12.690	13.000	12.969	USD 778	13.18
2025-02-11	BUY	240	12.240	12.910	12.843	USD 3,082	13.25

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRDA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	36,824	195	155,594	23.7%
2025-09-18	41,246	40	1,212,893	3.4%
2025-09-17	58,645	0	399,878	14.7%
2025-09-16	12,727	0	95,025	13.4%
2025-09-15	35,285	0	104,907	33.6%
2025-09-12	58,183	0	119,131	48.8%
2025-09-11	17,557	0	105,409	16.7%
2025-09-10	14,949	0	113,645	13.2%
2025-09-09	23,027	0	100,655	22.9%
2025-09-08	12,901	76	156,067	8.3%
2025-09-05	21,640	0	150,704	14.4%
2025-09-04	27,785	0	118,420	23.5%
2025-09-03	18,229	0	125,684	14.5%
2025-09-02	16,433	2,210	90,706	18.1%
2025-08-29	14,176	0	61,034	23.2%
2025-08-28	15,770	0	38,172	41.3%
2025-08-27	6,024	0	27,550	21.9%
2025-08-26	7,775	0	50,063	15.5%
2025-08-25	17,366	0	55,138	31.5%
2025-08-22	8,099	0	52,443	15.4%
2025-08-21	22,119	0	54,642	40.5%
2025-08-20	6,949	0	66,020	10.5%
2025-08-19	13,372	0	76,569	17.5%
2025-08-18	13,345	25	63,179	21.1%
2025-08-15	31,082	0	72,899	42.6%
2025-08-14	19,887	0	65,839	30.2%
2025-08-13	13,070	0	60,871	21.5%
2025-08-12	25,298	0	69,619	36.3%
2025-08-11	12,529	0	70,205	17.8%
2025-08-08	15,143	3,499	90,450	16.7%
2025-08-07	99,266	8,617	168,002	59.1%
2025-08-06	60,832	7,403	270,925	22.5%
2025-08-05	49,338	0	165,272	29.9%
2025-08-04	20,095	0	117,152	17.2%
2025-08-01	26,338	2,932	81,354	32.4%
2025-07-31	55,071	505	96,541	57.0%
2025-07-30	25,483	0	61,873	41.2%
2025-07-29	38,833	0	74,459	52.2%
2025-07-28	20,413	0	51,423	39.7%
2025-07-25	15,060	197	54,274	27.7%
2025-07-24	12,100	0	37,467	32.3%
2025-07-23	9,645	10	34,231	28.2%
2025-07-22	11,506	0	52,742	21.8%
2025-07-21	7,438	0	24,580	30.3%
2025-07-18	7,706	0	31,697	24.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE